Last €0.47 EUR
Change Today -0.004 / -0.84%
Volume 0.0
CRS1 On Other Exchanges
Symbol
Exchange
Continuous
Frankfurt
As of 7:13 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

ercros sa (CRS1) Snapshot

Open
€0.47
Previous Close
€0.47
Day High
€0.47
Day Low
€0.40
52 Week High
02/6/14 - €0.61
52 Week Low
08/13/13 - €0.34
Market Cap
52.2M
Average Volume 10 Days
30.7
EPS TTM
--
Shares Outstanding
111.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ERCROS SA (CRS1)

Related News

No related news articles were found.

ercros sa (CRS1) Related Businessweek News

No Related Businessweek News Found

ercros sa (CRS1) Details

Ercros, S.A. manufactures and markets basic and intermediate chemicals, plastics, and pharmaceuticals worldwide. Its Basic Chemicals division offers caustic potash and soda, chlorine, chloroisocyanurates, hydrochloric acid, and phosphates, as well as sodium chlorate, chloride, chlorite, and hypochlorite. The company’s products are used in pharmaceuticals, chemical industry, derivatives manufacturing, swimming pools, chemical industry, compound fodder, paper pulp bleaching, textile bleaching, and water treatment applications. Its Plastics division provides EDC, VCM, and PVC products for use in VCM and PVC manufacturing and construction applications. The company’s Intermediate Chemicals division offers formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol, and sodium formate, which are used in derivatives manufacturing, wood industry, electrotechnics, resins, paints, and tanning industry applications. Its Pharmaceuticals division provides erythromycins, fusidic acid, fosfomycins, and statins for use in antibiotic, eye infection, antibiotic, and antihypercholesterol product applications. The company was founded in 1817 and is headquartered in Barcelona, Spain.

Founded in 1817

ercros sa (CRS1) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ercros sa (CRS1) Key Developments

Ercros, S.A. expected to report Q2 2014 results on July 29, 2014. This event was calculated by Capital IQ (Created on May 22, 2014).

Ercros, S.A. expected to report Q2 2014 results on July 29, 2014. This event was calculated by Capital IQ (Created on May 22, 2014).

Ercros, S.A. Proposes Amendments to Articles of Association

Ercros, S.A. announced that at its AGM will be held on June 26, 2014, proposed amendments of Articles 25 and 27 of the company's articles of association to adapt them to legislative novelties and introduce improvements to the good governance of the company.

Ercros, S.A., Annual General Meeting, Jun 26, 2014

Ercros, S.A., Annual General Meeting, Jun 26, 2014., at 12:00 Central European Standard Time. Location: Mutua General de Seguros. Agenda: To consider the examination and approval of the individual and consolidated financial statements; to consider the approval of the amendment of articles of association; to consider the re-election of Ernst & Young as the auditor of the company; to consider the authorization in order for the company to acquire treasury shares; to consider the delegation to the board of directors of the power to increase the share capital; to consider the delegation to the board of directors of the power to issue negotiable securities; and to consider the delegation to the board of directors of the powers, in the broadest terms, to interpret, rectify, supplement, execute and carry out the resolutions adopted by the shareholders at the General Meeting, as well as replace any powers that it may receive from the General Meeting and to grant powers to convert these resolutions in public deeds.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRS1:GR €0.47 EUR -0.004

CRS1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CRS1.
View Industry Companies
 

Industry Analysis

CRS1

Industry Average

Valuation CRS1 Industry Range
Price/Earnings 11.8x
Price/Sales 0.1x
Price/Book 0.3x
Price/Cash Flow 2.6x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERCROS SA, please visit www.ercros.es. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.